miR-448 Inhibition to Restore Cardiac Sodium Current

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing therapies for cardiac arrhythmias associated with reduced sodium current in cardiac cells, such as those occurring after myocardial infarction, are limited, and the mechanisms by which ischemia causes downregulation of the cardiac voltage-gated sodium channel α-subunit (SCN5A) are unclear.

Innovation Solution

Introducing an miR-448 inhibitor to decrease miR-448 suppression of SCN5A mRNA transcription, thereby increasing sodium current in cardiac cells, using methods such as administering an miR-448 inhibitor or using an miR-448 sponge to inhibit miR-448 function.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If miR-488 is introduced to suppress SCN5A mRNA transcription, then sodium current is reduced, but arrhythmic risk increases

Engineering Contradiction:

Improvearrhythmic riskVSAvoidsodium current reduction

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

Instead of using miR-488 to suppress SCN5A (which reduces sodium current and increases arrhythmia risk), the invention introduces an miR-488 inhibitor that blocks miR-488 activity. This inverts the regulatory direction: by preventing miR-488 from suppressing SCN5A mRNA, the invention increases sodium current while reducing arrhythmic risk, thereby resolving the harmful effect of miR-488 overexpression in ischemic cardiomyopathy

Inventive Principle:

Principle #13The other way round (Inversion)

2Quantity of substance

If miR-488 suppression of SCN5A mRNA is increased, then translation is decreased, but sodium channel expression is reduced

Engineering Contradiction:

ImproveSCN5A mRNA translationVSAvoidsodium channel expression

Core Design Contradiction:

Quantity of substanceVSReliability

Solution Approach 1:

The invention uses an miR-488 inhibitor as an intermediary molecule that blocks the interaction between miR-488 and SCN5A mRNA. This intermediary prevents miR-488 from binding to and suppressing SCN5A mRNA translation, thereby restoring sodium channel expression without directly manipulating the SCN5A gene itself. The inhibitor acts as a mediator that reverses the pathological suppression caused by miR-488 overexpression

Inventive Principle:

Principle #24Intermediary (Mediator)

Data Source

PatentUS12612627B2Compositions and methods for increasing sodium current in cardiac cells

Publication Date: 2026.04.28 REGENTS OF THE UNIVERSITY OF MINNESOTA

AI summary

A method of increasing sodium current in a cardiac cell generally includes introducing into the cardiac cell an miR-448 inhibitor in an amount effective to decrease miR-448 suppression of SCN5A mRNA transcription, thereby increasing sodium current in the cardiac cell. A method of increasing translation of SCN5A mRNA in a cell generally includes introducing into the cell an miR-448 inhibitor in an amount effective to decrease miR-448 suppression of SCN5A mRNA transcription. A method of decreasing arrythmia in a cardiac cell generally includes introducing into the cardiac cell an miR-448 inhibitor in an amount effective to decrease miR-448 suppression of SCN5A mRNA transcription. A method of treating arrythmia in a patient having, or at risk of having, arrythmia generally includes administering to the patient an miR-448 inhibitor in an amount effective to decrease the likelihood or extent of arrythmia in the patient. In some embodiments of all methods, the miR-448 inhibitor can be an miR-448 antagomir or an miR-448 sponge.